Global Albumin (as Excipient) Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Albumin (as Excipient) market size is predicted to grow from US$ 4776 million in 2025 to US$ 6901 million in 2031; it is expected to grow at a CAGR of 6.3% from 2025 to 2031.
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.
By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.
LP Information, Inc. (LPI) ' newest research report, the “Albumin (as Excipient) Industry Forecast” looks at past sales and reviews total world Albumin (as Excipient) sales in 2024, providing a comprehensive analysis by region and market sector of projected Albumin (as Excipient) sales for 2025 through 2031. With Albumin (as Excipient) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Albumin (as Excipient) industry.
This Insight Report provides a comprehensive analysis of the global Albumin (as Excipient) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Albumin (as Excipient) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Albumin (as Excipient) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Albumin (as Excipient) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Albumin (as Excipient).
This report presents a comprehensive overview, market shares, and growth opportunities of Albumin (as Excipient) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Albumin (as Excipient) market?
What factors are driving Albumin (as Excipient) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Albumin (as Excipient) market opportunities vary by end market size?
How does Albumin (as Excipient) break out by Type, by Application?
The global Albumin (as Excipient) market size is predicted to grow from US$ 4776 million in 2025 to US$ 6901 million in 2031; it is expected to grow at a CAGR of 6.3% from 2025 to 2031.
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.
By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.
LP Information, Inc. (LPI) ' newest research report, the “Albumin (as Excipient) Industry Forecast” looks at past sales and reviews total world Albumin (as Excipient) sales in 2024, providing a comprehensive analysis by region and market sector of projected Albumin (as Excipient) sales for 2025 through 2031. With Albumin (as Excipient) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Albumin (as Excipient) industry.
This Insight Report provides a comprehensive analysis of the global Albumin (as Excipient) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Albumin (as Excipient) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Albumin (as Excipient) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Albumin (as Excipient) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Albumin (as Excipient).
This report presents a comprehensive overview, market shares, and growth opportunities of Albumin (as Excipient) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Human Serum Albumin
- Recombinant Albumin
- Cell Culture Media
- Medical Supplements
- Therapeutics
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CSL
- Grifols
- Takeda
- Octapharma
- Hualan Bio
- CBPO
- Shanghai RAAS
- Kedrion
- LFB Group
- Albumedix
- Biotest
- Merck
- Ventria (InVitria)
- HiMedia
What is the 10-year outlook for the global Albumin (as Excipient) market?
What factors are driving Albumin (as Excipient) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Albumin (as Excipient) market opportunities vary by end market size?
How does Albumin (as Excipient) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Albumin (as Excipient) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Albumin (as Excipient) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Albumin (as Excipient) by Country/Region, 2020, 2024 & 2031
2.2 Albumin (as Excipient) Segment by Type
2.2.1 Human Serum Albumin
2.2.2 Recombinant Albumin
2.3 Albumin (as Excipient) Sales by Type
2.3.1 Global Albumin (as Excipient) Sales Market Share by Type (2020-2025)
2.3.2 Global Albumin (as Excipient) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Albumin (as Excipient) Sale Price by Type (2020-2025)
2.4 Albumin (as Excipient) Segment by Application
2.4.1 Cell Culture Media
2.4.2 Medical Supplements
2.4.3 Therapeutics
2.5 Albumin (as Excipient) Sales by Application
2.5.1 Global Albumin (as Excipient) Sale Market Share by Application (2020-2025)
2.5.2 Global Albumin (as Excipient) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Albumin (as Excipient) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Albumin (as Excipient) Breakdown Data by Company
3.1.1 Global Albumin (as Excipient) Annual Sales by Company (2020-2025)
3.1.2 Global Albumin (as Excipient) Sales Market Share by Company (2020-2025)
3.2 Global Albumin (as Excipient) Annual Revenue by Company (2020-2025)
3.2.1 Global Albumin (as Excipient) Revenue by Company (2020-2025)
3.2.2 Global Albumin (as Excipient) Revenue Market Share by Company (2020-2025)
3.3 Global Albumin (as Excipient) Sale Price by Company
3.4 Key Manufacturers Albumin (as Excipient) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Albumin (as Excipient) Product Location Distribution
3.4.2 Players Albumin (as Excipient) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ALBUMIN (AS EXCIPIENT) BY GEOGRAPHIC REGION
4.1 World Historic Albumin (as Excipient) Market Size by Geographic Region (2020-2025)
4.1.1 Global Albumin (as Excipient) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Albumin (as Excipient) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Albumin (as Excipient) Market Size by Country/Region (2020-2025)
4.2.1 Global Albumin (as Excipient) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Albumin (as Excipient) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Albumin (as Excipient) Sales Growth
4.4 APAC Albumin (as Excipient) Sales Growth
4.5 Europe Albumin (as Excipient) Sales Growth
4.6 Middle East & Africa Albumin (as Excipient) Sales Growth
5 AMERICAS
5.1 Americas Albumin (as Excipient) Sales by Country
5.1.1 Americas Albumin (as Excipient) Sales by Country (2020-2025)
5.1.2 Americas Albumin (as Excipient) Revenue by Country (2020-2025)
5.2 Americas Albumin (as Excipient) Sales by Type (2020-2025)
5.3 Americas Albumin (as Excipient) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Albumin (as Excipient) Sales by Region
6.1.1 APAC Albumin (as Excipient) Sales by Region (2020-2025)
6.1.2 APAC Albumin (as Excipient) Revenue by Region (2020-2025)
6.2 APAC Albumin (as Excipient) Sales by Type (2020-2025)
6.3 APAC Albumin (as Excipient) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Albumin (as Excipient) by Country
7.1.1 Europe Albumin (as Excipient) Sales by Country (2020-2025)
7.1.2 Europe Albumin (as Excipient) Revenue by Country (2020-2025)
7.2 Europe Albumin (as Excipient) Sales by Type (2020-2025)
7.3 Europe Albumin (as Excipient) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Albumin (as Excipient) by Country
8.1.1 Middle East & Africa Albumin (as Excipient) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Albumin (as Excipient) Revenue by Country (2020-2025)
8.2 Middle East & Africa Albumin (as Excipient) Sales by Type (2020-2025)
8.3 Middle East & Africa Albumin (as Excipient) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Albumin (as Excipient)
10.3 Manufacturing Process Analysis of Albumin (as Excipient)
10.4 Industry Chain Structure of Albumin (as Excipient)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Albumin (as Excipient) Distributors
11.3 Albumin (as Excipient) Customer
12 WORLD FORECAST REVIEW FOR ALBUMIN (AS EXCIPIENT) BY GEOGRAPHIC REGION
12.1 Global Albumin (as Excipient) Market Size Forecast by Region
12.1.1 Global Albumin (as Excipient) Forecast by Region (2026-2031)
12.1.2 Global Albumin (as Excipient) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Albumin (as Excipient) Forecast by Type (2026-2031)
12.7 Global Albumin (as Excipient) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 CSL
13.1.1 CSL Company Information
13.1.2 CSL Albumin (as Excipient) Product Portfolios and Specifications
13.1.3 CSL Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 CSL Main Business Overview
13.1.5 CSL Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Albumin (as Excipient) Product Portfolios and Specifications
13.2.3 Grifols Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Takeda
13.3.1 Takeda Company Information
13.3.2 Takeda Albumin (as Excipient) Product Portfolios and Specifications
13.3.3 Takeda Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Takeda Main Business Overview
13.3.5 Takeda Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Albumin (as Excipient) Product Portfolios and Specifications
13.4.3 Octapharma Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Hualan Bio
13.5.1 Hualan Bio Company Information
13.5.2 Hualan Bio Albumin (as Excipient) Product Portfolios and Specifications
13.5.3 Hualan Bio Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Hualan Bio Main Business Overview
13.5.5 Hualan Bio Latest Developments
13.6 CBPO
13.6.1 CBPO Company Information
13.6.2 CBPO Albumin (as Excipient) Product Portfolios and Specifications
13.6.3 CBPO Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 CBPO Main Business Overview
13.6.5 CBPO Latest Developments
13.7 Shanghai RAAS
13.7.1 Shanghai RAAS Company Information
13.7.2 Shanghai RAAS Albumin (as Excipient) Product Portfolios and Specifications
13.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Shanghai RAAS Main Business Overview
13.7.5 Shanghai RAAS Latest Developments
13.8 Kedrion
13.8.1 Kedrion Company Information
13.8.2 Kedrion Albumin (as Excipient) Product Portfolios and Specifications
13.8.3 Kedrion Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Kedrion Main Business Overview
13.8.5 Kedrion Latest Developments
13.9 LFB Group
13.9.1 LFB Group Company Information
13.9.2 LFB Group Albumin (as Excipient) Product Portfolios and Specifications
13.9.3 LFB Group Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 LFB Group Main Business Overview
13.9.5 LFB Group Latest Developments
13.10 Albumedix
13.10.1 Albumedix Company Information
13.10.2 Albumedix Albumin (as Excipient) Product Portfolios and Specifications
13.10.3 Albumedix Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Albumedix Main Business Overview
13.10.5 Albumedix Latest Developments
13.11 Biotest
13.11.1 Biotest Company Information
13.11.2 Biotest Albumin (as Excipient) Product Portfolios and Specifications
13.11.3 Biotest Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Biotest Main Business Overview
13.11.5 Biotest Latest Developments
13.12 Merck
13.12.1 Merck Company Information
13.12.2 Merck Albumin (as Excipient) Product Portfolios and Specifications
13.12.3 Merck Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Merck Main Business Overview
13.12.5 Merck Latest Developments
13.13 Ventria (InVitria)
13.13.1 Ventria (InVitria) Company Information
13.13.2 Ventria (InVitria) Albumin (as Excipient) Product Portfolios and Specifications
13.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Ventria (InVitria) Main Business Overview
13.13.5 Ventria (InVitria) Latest Developments
13.14 HiMedia
13.14.1 HiMedia Company Information
13.14.2 HiMedia Albumin (as Excipient) Product Portfolios and Specifications
13.14.3 HiMedia Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 HiMedia Main Business Overview
13.14.5 HiMedia Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Albumin (as Excipient) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Albumin (as Excipient) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Human Serum Albumin
Table 4. Major Players of Recombinant Albumin
Table 5. Global Albumin (as Excipient) Sales byType (2020-2025) & (MT)
Table 6. Global Albumin (as Excipient) Sales Market Share byType (2020-2025)
Table 7. Global Albumin (as Excipient) Revenue byType (2020-2025) & ($ million)
Table 8. Global Albumin (as Excipient) Revenue Market Share byType (2020-2025)
Table 9. Global Albumin (as Excipient) Sale Price byType (2020-2025) & (USD/Kg)
Table 10. Global Albumin (as Excipient) Sale by Application (2020-2025) & (MT)
Table 11. Global Albumin (as Excipient) Sale Market Share by Application (2020-2025)
Table 12. Global Albumin (as Excipient) Revenue by Application (2020-2025) & ($ million)
Table 13. Global Albumin (as Excipient) Revenue Market Share by Application (2020-2025)
Table 14. Global Albumin (as Excipient) Sale Price by Application (2020-2025) & (USD/Kg)
Table 15. Global Albumin (as Excipient) Sales by Company (2020-2025) & (MT)
Table 16. Global Albumin (as Excipient) Sales Market Share by Company (2020-2025)
Table 17. Global Albumin (as Excipient) Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Albumin (as Excipient) Revenue Market Share by Company (2020-2025)
Table 19. Global Albumin (as Excipient) Sale Price by Company (2020-2025) & (USD/Kg)
Table 20. Key Manufacturers Albumin (as Excipient) Producing Area Distribution and Sales Area
Table 21. Players Albumin (as Excipient) Products Offered
Table 22. Albumin (as Excipient) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Albumin (as Excipient) Sales by Geographic Region (2020-2025) & (MT)
Table 26. Global Albumin (as Excipient) Sales Market Share Geographic Region (2020-2025)
Table 27. Global Albumin (as Excipient) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Albumin (as Excipient) Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Albumin (as Excipient) Sales by Country/Region (2020-2025) & (MT)
Table 30. Global Albumin (as Excipient) Sales Market Share by Country/Region (2020-2025)
Table 31. Global Albumin (as Excipient) Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Albumin (as Excipient) Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Albumin (as Excipient) Sales by Country (2020-2025) & (MT)
Table 34. Americas Albumin (as Excipient) Sales Market Share by Country (2020-2025)
Table 35. Americas Albumin (as Excipient) Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Albumin (as Excipient) Sales byType (2020-2025) & (MT)
Table 37. Americas Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 38. APAC Albumin (as Excipient) Sales by Region (2020-2025) & (MT)
Table 39. APAC Albumin (as Excipient) Sales Market Share by Region (2020-2025)
Table 40. APAC Albumin (as Excipient) Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Albumin (as Excipient) Sales byType (2020-2025) & (MT)
Table 42. APAC Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 43. Europe Albumin (as Excipient) Sales by Country (2020-2025) & (MT)
Table 44. Europe Albumin (as Excipient) Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Albumin (as Excipient) Sales byType (2020-2025) & (MT)
Table 46. Europe Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 47. Middle East & Africa Albumin (as Excipient) Sales by Country (2020-2025) & (MT)
Table 48. Middle East & Africa Albumin (as Excipient) Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Albumin (as Excipient) Sales byType (2020-2025) & (MT)
Table 50. Middle East & Africa Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 51. Key Market Drivers & Growth Opportunities of Albumin (as Excipient)
Table 52. Key Market Challenges & Risks of Albumin (as Excipient)
Table 53. Key IndustryTrends of Albumin (as Excipient)
Table 54. Albumin (as Excipient) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Albumin (as Excipient) Distributors List
Table 57. Albumin (as Excipient) Customer List
Table 58. Global Albumin (as Excipient) SalesForecast by Region (2026-2031) & (MT)
Table 59. Global Albumin (as Excipient) RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Albumin (as Excipient) SalesForecast by Country (2026-2031) & (MT)
Table 61. Americas Albumin (as Excipient) Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Albumin (as Excipient) SalesForecast by Region (2026-2031) & (MT)
Table 63. APAC Albumin (as Excipient) Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Albumin (as Excipient) SalesForecast by Country (2026-2031) & (MT)
Table 65. Europe Albumin (as Excipient) RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Albumin (as Excipient) SalesForecast by Country (2026-2031) & (MT)
Table 67. Middle East & Africa Albumin (as Excipient) RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Albumin (as Excipient) SalesForecast byType (2026-2031) & (MT)
Table 69. Global Albumin (as Excipient) RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Albumin (as Excipient) SalesForecast by Application (2026-2031) & (MT)
Table 71. Global Albumin (as Excipient) RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. CSL Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 73. CSL Albumin (as Excipient) Product Portfolios and Specifications
Table 74. CSL Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. CSL Main Business
Table 76. CSL Latest Developments
Table 77. Grifols Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 78. Grifols Albumin (as Excipient) Product Portfolios and Specifications
Table 79. Grifols Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. Grifols Main Business
Table 81. Grifols Latest Developments
Table 82.Takeda Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 83.Takeda Albumin (as Excipient) Product Portfolios and Specifications
Table 84.Takeda Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 85.Takeda Main Business
Table 86.Takeda Latest Developments
Table 87. Octapharma Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 88. Octapharma Albumin (as Excipient) Product Portfolios and Specifications
Table 89. Octapharma Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 90. Octapharma Main Business
Table 91. Octapharma Latest Developments
Table 92. Hualan Bio Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 93. Hualan Bio Albumin (as Excipient) Product Portfolios and Specifications
Table 94. Hualan Bio Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 95. Hualan Bio Main Business
Table 96. Hualan Bio Latest Developments
Table 97. CBPO Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 98. CBPO Albumin (as Excipient) Product Portfolios and Specifications
Table 99. CBPO Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 100. CBPO Main Business
Table 101. CBPO Latest Developments
Table 102. Shanghai RAAS Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 103. Shanghai RAAS Albumin (as Excipient) Product Portfolios and Specifications
Table 104. Shanghai RAAS Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 105. Shanghai RAAS Main Business
Table 106. Shanghai RAAS Latest Developments
Table 107. Kedrion Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 108. Kedrion Albumin (as Excipient) Product Portfolios and Specifications
Table 109. Kedrion Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 110. Kedrion Main Business
Table 111. Kedrion Latest Developments
Table 112. LFB Group Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 113. LFB Group Albumin (as Excipient) Product Portfolios and Specifications
Table 114. LFB Group Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 115. LFB Group Main Business
Table 116. LFB Group Latest Developments
Table 117. Albumedix Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 118. Albumedix Albumin (as Excipient) Product Portfolios and Specifications
Table 119. Albumedix Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 120. Albumedix Main Business
Table 121. Albumedix Latest Developments
Table 122. Biotest Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 123. Biotest Albumin (as Excipient) Product Portfolios and Specifications
Table 124. Biotest Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 125. Biotest Main Business
Table 126. Biotest Latest Developments
Table 127. Merck Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 128. Merck Albumin (as Excipient) Product Portfolios and Specifications
Table 129. Merck Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 130. Merck Main Business
Table 131. Merck Latest Developments
Table 132. Ventria (InVitria) Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 133. Ventria (InVitria) Albumin (as Excipient) Product Portfolios and Specifications
Table 134. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 135. Ventria (InVitria) Main Business
Table 136. Ventria (InVitria) Latest Developments
Table 137. HiMedia Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 138. HiMedia Albumin (as Excipient) Product Portfolios and Specifications
Table 139. HiMedia Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 140. HiMedia Main Business
Table 141. HiMedia Latest Developments
LIST OFFIGURES
Figure 1. Picture of Albumin (as Excipient)
Figure 2. Albumin (as Excipient) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Albumin (as Excipient) Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Albumin (as Excipient) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Albumin (as Excipient) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Albumin (as Excipient) Sales Market Share by Country/Region (2024)
Figure 10. Albumin (as Excipient) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Human Serum Albumin
Figure 12. Product Picture of Recombinant Albumin
Figure 13. Global Albumin (as Excipient) Sales Market Share byType in 2025
Figure 14. Global Albumin (as Excipient) Revenue Market Share byType (2020-2025)
Figure 15. Albumin (as Excipient) Consumed in Cell Culture Media
Figure 16. Global Albumin (as Excipient) Market: Cell Culture Media (2020-2025) & (MT)
Figure 17. Albumin (as Excipient) Consumed in Medical Supplements
Figure 18. Global Albumin (as Excipient) Market: Medical Supplements (2020-2025) & (MT)
Figure 19. Albumin (as Excipient) Consumed inTherapeutics
Figure 20. Global Albumin (as Excipient) Market:Therapeutics (2020-2025) & (MT)
Figure 21. Global Albumin (as Excipient) Sale Market Share by Application (2024)
Figure 22. Global Albumin (as Excipient) Revenue Market Share by Application in 2025
Figure 23. Albumin (as Excipient) Sales by Company in 2025 (MT)
Figure 24. Global Albumin (as Excipient) Sales Market Share by Company in 2025
Figure 25. Albumin (as Excipient) Revenue by Company in 2025 ($ millions)
Figure 26. Global Albumin (as Excipient) Revenue Market Share by Company in 2025
Figure 27. Global Albumin (as Excipient) Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Albumin (as Excipient) Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Albumin (as Excipient) Sales 2020-2025 (MT)
Figure 30. Americas Albumin (as Excipient) Revenue 2020-2025 ($ millions)
Figure 31. APAC Albumin (as Excipient) Sales 2020-2025 (MT)
Figure 32. APAC Albumin (as Excipient) Revenue 2020-2025 ($ millions)
Figure 33. Europe Albumin (as Excipient) Sales 2020-2025 (MT)
Figure 34. Europe Albumin (as Excipient) Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Albumin (as Excipient) Sales 2020-2025 (MT)
Figure 36. Middle East & Africa Albumin (as Excipient) Revenue 2020-2025 ($ millions)
Figure 37. Americas Albumin (as Excipient) Sales Market Share by Country in 2025
Figure 38. Americas Albumin (as Excipient) Revenue Market Share by Country (2020-2025)
Figure 39. Americas Albumin (as Excipient) Sales Market Share byType (2020-2025)
Figure 40. Americas Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Figure 41. United States Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Albumin (as Excipient) Sales Market Share by Region in 2025
Figure 46. APAC Albumin (as Excipient) Revenue Market Share by Region (2020-2025)
Figure 47. APAC Albumin (as Excipient) Sales Market Share byType (2020-2025)
Figure 48. APAC Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Figure 49. China Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 53. India Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Albumin (as Excipient) Sales Market Share by Country in 2025
Figure 57. Europe Albumin (as Excipient) Revenue Market Share by Country (2020-2025)
Figure 58. Europe Albumin (as Excipient) Sales Market Share byType (2020-2025)
Figure 59. Europe Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Figure 60. Germany Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 61.France Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Albumin (as Excipient) Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Albumin (as Excipient) Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Figure 68. Egypt Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Albumin (as Excipient) in 2025
Figure 74. Manufacturing Process Analysis of Albumin (as Excipient)
Figure 75. Industry Chain Structure of Albumin (as Excipient)
Figure 76. Channels of Distribution
Figure 77. Global Albumin (as Excipient) Sales MarketForecast by Region (2026-2031)
Figure 78. Global Albumin (as Excipient) Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Albumin (as Excipient) Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Albumin (as Excipient) Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Albumin (as Excipient) Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Albumin (as Excipient) Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Albumin (as Excipient) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Albumin (as Excipient) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Albumin (as Excipient) by Country/Region, 2020, 2024 & 2031
2.2 Albumin (as Excipient) Segment by Type
2.2.1 Human Serum Albumin
2.2.2 Recombinant Albumin
2.3 Albumin (as Excipient) Sales by Type
2.3.1 Global Albumin (as Excipient) Sales Market Share by Type (2020-2025)
2.3.2 Global Albumin (as Excipient) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Albumin (as Excipient) Sale Price by Type (2020-2025)
2.4 Albumin (as Excipient) Segment by Application
2.4.1 Cell Culture Media
2.4.2 Medical Supplements
2.4.3 Therapeutics
2.5 Albumin (as Excipient) Sales by Application
2.5.1 Global Albumin (as Excipient) Sale Market Share by Application (2020-2025)
2.5.2 Global Albumin (as Excipient) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Albumin (as Excipient) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Albumin (as Excipient) Breakdown Data by Company
3.1.1 Global Albumin (as Excipient) Annual Sales by Company (2020-2025)
3.1.2 Global Albumin (as Excipient) Sales Market Share by Company (2020-2025)
3.2 Global Albumin (as Excipient) Annual Revenue by Company (2020-2025)
3.2.1 Global Albumin (as Excipient) Revenue by Company (2020-2025)
3.2.2 Global Albumin (as Excipient) Revenue Market Share by Company (2020-2025)
3.3 Global Albumin (as Excipient) Sale Price by Company
3.4 Key Manufacturers Albumin (as Excipient) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Albumin (as Excipient) Product Location Distribution
3.4.2 Players Albumin (as Excipient) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ALBUMIN (AS EXCIPIENT) BY GEOGRAPHIC REGION
4.1 World Historic Albumin (as Excipient) Market Size by Geographic Region (2020-2025)
4.1.1 Global Albumin (as Excipient) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Albumin (as Excipient) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Albumin (as Excipient) Market Size by Country/Region (2020-2025)
4.2.1 Global Albumin (as Excipient) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Albumin (as Excipient) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Albumin (as Excipient) Sales Growth
4.4 APAC Albumin (as Excipient) Sales Growth
4.5 Europe Albumin (as Excipient) Sales Growth
4.6 Middle East & Africa Albumin (as Excipient) Sales Growth
5 AMERICAS
5.1 Americas Albumin (as Excipient) Sales by Country
5.1.1 Americas Albumin (as Excipient) Sales by Country (2020-2025)
5.1.2 Americas Albumin (as Excipient) Revenue by Country (2020-2025)
5.2 Americas Albumin (as Excipient) Sales by Type (2020-2025)
5.3 Americas Albumin (as Excipient) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Albumin (as Excipient) Sales by Region
6.1.1 APAC Albumin (as Excipient) Sales by Region (2020-2025)
6.1.2 APAC Albumin (as Excipient) Revenue by Region (2020-2025)
6.2 APAC Albumin (as Excipient) Sales by Type (2020-2025)
6.3 APAC Albumin (as Excipient) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Albumin (as Excipient) by Country
7.1.1 Europe Albumin (as Excipient) Sales by Country (2020-2025)
7.1.2 Europe Albumin (as Excipient) Revenue by Country (2020-2025)
7.2 Europe Albumin (as Excipient) Sales by Type (2020-2025)
7.3 Europe Albumin (as Excipient) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Albumin (as Excipient) by Country
8.1.1 Middle East & Africa Albumin (as Excipient) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Albumin (as Excipient) Revenue by Country (2020-2025)
8.2 Middle East & Africa Albumin (as Excipient) Sales by Type (2020-2025)
8.3 Middle East & Africa Albumin (as Excipient) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Albumin (as Excipient)
10.3 Manufacturing Process Analysis of Albumin (as Excipient)
10.4 Industry Chain Structure of Albumin (as Excipient)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Albumin (as Excipient) Distributors
11.3 Albumin (as Excipient) Customer
12 WORLD FORECAST REVIEW FOR ALBUMIN (AS EXCIPIENT) BY GEOGRAPHIC REGION
12.1 Global Albumin (as Excipient) Market Size Forecast by Region
12.1.1 Global Albumin (as Excipient) Forecast by Region (2026-2031)
12.1.2 Global Albumin (as Excipient) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Albumin (as Excipient) Forecast by Type (2026-2031)
12.7 Global Albumin (as Excipient) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 CSL
13.1.1 CSL Company Information
13.1.2 CSL Albumin (as Excipient) Product Portfolios and Specifications
13.1.3 CSL Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 CSL Main Business Overview
13.1.5 CSL Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Albumin (as Excipient) Product Portfolios and Specifications
13.2.3 Grifols Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Takeda
13.3.1 Takeda Company Information
13.3.2 Takeda Albumin (as Excipient) Product Portfolios and Specifications
13.3.3 Takeda Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Takeda Main Business Overview
13.3.5 Takeda Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Albumin (as Excipient) Product Portfolios and Specifications
13.4.3 Octapharma Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Hualan Bio
13.5.1 Hualan Bio Company Information
13.5.2 Hualan Bio Albumin (as Excipient) Product Portfolios and Specifications
13.5.3 Hualan Bio Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Hualan Bio Main Business Overview
13.5.5 Hualan Bio Latest Developments
13.6 CBPO
13.6.1 CBPO Company Information
13.6.2 CBPO Albumin (as Excipient) Product Portfolios and Specifications
13.6.3 CBPO Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 CBPO Main Business Overview
13.6.5 CBPO Latest Developments
13.7 Shanghai RAAS
13.7.1 Shanghai RAAS Company Information
13.7.2 Shanghai RAAS Albumin (as Excipient) Product Portfolios and Specifications
13.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Shanghai RAAS Main Business Overview
13.7.5 Shanghai RAAS Latest Developments
13.8 Kedrion
13.8.1 Kedrion Company Information
13.8.2 Kedrion Albumin (as Excipient) Product Portfolios and Specifications
13.8.3 Kedrion Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Kedrion Main Business Overview
13.8.5 Kedrion Latest Developments
13.9 LFB Group
13.9.1 LFB Group Company Information
13.9.2 LFB Group Albumin (as Excipient) Product Portfolios and Specifications
13.9.3 LFB Group Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 LFB Group Main Business Overview
13.9.5 LFB Group Latest Developments
13.10 Albumedix
13.10.1 Albumedix Company Information
13.10.2 Albumedix Albumin (as Excipient) Product Portfolios and Specifications
13.10.3 Albumedix Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Albumedix Main Business Overview
13.10.5 Albumedix Latest Developments
13.11 Biotest
13.11.1 Biotest Company Information
13.11.2 Biotest Albumin (as Excipient) Product Portfolios and Specifications
13.11.3 Biotest Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Biotest Main Business Overview
13.11.5 Biotest Latest Developments
13.12 Merck
13.12.1 Merck Company Information
13.12.2 Merck Albumin (as Excipient) Product Portfolios and Specifications
13.12.3 Merck Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Merck Main Business Overview
13.12.5 Merck Latest Developments
13.13 Ventria (InVitria)
13.13.1 Ventria (InVitria) Company Information
13.13.2 Ventria (InVitria) Albumin (as Excipient) Product Portfolios and Specifications
13.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Ventria (InVitria) Main Business Overview
13.13.5 Ventria (InVitria) Latest Developments
13.14 HiMedia
13.14.1 HiMedia Company Information
13.14.2 HiMedia Albumin (as Excipient) Product Portfolios and Specifications
13.14.3 HiMedia Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 HiMedia Main Business Overview
13.14.5 HiMedia Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Albumin (as Excipient) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Albumin (as Excipient) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Human Serum Albumin
Table 4. Major Players of Recombinant Albumin
Table 5. Global Albumin (as Excipient) Sales byType (2020-2025) & (MT)
Table 6. Global Albumin (as Excipient) Sales Market Share byType (2020-2025)
Table 7. Global Albumin (as Excipient) Revenue byType (2020-2025) & ($ million)
Table 8. Global Albumin (as Excipient) Revenue Market Share byType (2020-2025)
Table 9. Global Albumin (as Excipient) Sale Price byType (2020-2025) & (USD/Kg)
Table 10. Global Albumin (as Excipient) Sale by Application (2020-2025) & (MT)
Table 11. Global Albumin (as Excipient) Sale Market Share by Application (2020-2025)
Table 12. Global Albumin (as Excipient) Revenue by Application (2020-2025) & ($ million)
Table 13. Global Albumin (as Excipient) Revenue Market Share by Application (2020-2025)
Table 14. Global Albumin (as Excipient) Sale Price by Application (2020-2025) & (USD/Kg)
Table 15. Global Albumin (as Excipient) Sales by Company (2020-2025) & (MT)
Table 16. Global Albumin (as Excipient) Sales Market Share by Company (2020-2025)
Table 17. Global Albumin (as Excipient) Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Albumin (as Excipient) Revenue Market Share by Company (2020-2025)
Table 19. Global Albumin (as Excipient) Sale Price by Company (2020-2025) & (USD/Kg)
Table 20. Key Manufacturers Albumin (as Excipient) Producing Area Distribution and Sales Area
Table 21. Players Albumin (as Excipient) Products Offered
Table 22. Albumin (as Excipient) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Albumin (as Excipient) Sales by Geographic Region (2020-2025) & (MT)
Table 26. Global Albumin (as Excipient) Sales Market Share Geographic Region (2020-2025)
Table 27. Global Albumin (as Excipient) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Albumin (as Excipient) Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Albumin (as Excipient) Sales by Country/Region (2020-2025) & (MT)
Table 30. Global Albumin (as Excipient) Sales Market Share by Country/Region (2020-2025)
Table 31. Global Albumin (as Excipient) Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Albumin (as Excipient) Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Albumin (as Excipient) Sales by Country (2020-2025) & (MT)
Table 34. Americas Albumin (as Excipient) Sales Market Share by Country (2020-2025)
Table 35. Americas Albumin (as Excipient) Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Albumin (as Excipient) Sales byType (2020-2025) & (MT)
Table 37. Americas Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 38. APAC Albumin (as Excipient) Sales by Region (2020-2025) & (MT)
Table 39. APAC Albumin (as Excipient) Sales Market Share by Region (2020-2025)
Table 40. APAC Albumin (as Excipient) Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Albumin (as Excipient) Sales byType (2020-2025) & (MT)
Table 42. APAC Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 43. Europe Albumin (as Excipient) Sales by Country (2020-2025) & (MT)
Table 44. Europe Albumin (as Excipient) Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Albumin (as Excipient) Sales byType (2020-2025) & (MT)
Table 46. Europe Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 47. Middle East & Africa Albumin (as Excipient) Sales by Country (2020-2025) & (MT)
Table 48. Middle East & Africa Albumin (as Excipient) Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Albumin (as Excipient) Sales byType (2020-2025) & (MT)
Table 50. Middle East & Africa Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 51. Key Market Drivers & Growth Opportunities of Albumin (as Excipient)
Table 52. Key Market Challenges & Risks of Albumin (as Excipient)
Table 53. Key IndustryTrends of Albumin (as Excipient)
Table 54. Albumin (as Excipient) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Albumin (as Excipient) Distributors List
Table 57. Albumin (as Excipient) Customer List
Table 58. Global Albumin (as Excipient) SalesForecast by Region (2026-2031) & (MT)
Table 59. Global Albumin (as Excipient) RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Albumin (as Excipient) SalesForecast by Country (2026-2031) & (MT)
Table 61. Americas Albumin (as Excipient) Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Albumin (as Excipient) SalesForecast by Region (2026-2031) & (MT)
Table 63. APAC Albumin (as Excipient) Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Albumin (as Excipient) SalesForecast by Country (2026-2031) & (MT)
Table 65. Europe Albumin (as Excipient) RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Albumin (as Excipient) SalesForecast by Country (2026-2031) & (MT)
Table 67. Middle East & Africa Albumin (as Excipient) RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Albumin (as Excipient) SalesForecast byType (2026-2031) & (MT)
Table 69. Global Albumin (as Excipient) RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Albumin (as Excipient) SalesForecast by Application (2026-2031) & (MT)
Table 71. Global Albumin (as Excipient) RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. CSL Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 73. CSL Albumin (as Excipient) Product Portfolios and Specifications
Table 74. CSL Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. CSL Main Business
Table 76. CSL Latest Developments
Table 77. Grifols Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 78. Grifols Albumin (as Excipient) Product Portfolios and Specifications
Table 79. Grifols Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. Grifols Main Business
Table 81. Grifols Latest Developments
Table 82.Takeda Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 83.Takeda Albumin (as Excipient) Product Portfolios and Specifications
Table 84.Takeda Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 85.Takeda Main Business
Table 86.Takeda Latest Developments
Table 87. Octapharma Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 88. Octapharma Albumin (as Excipient) Product Portfolios and Specifications
Table 89. Octapharma Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 90. Octapharma Main Business
Table 91. Octapharma Latest Developments
Table 92. Hualan Bio Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 93. Hualan Bio Albumin (as Excipient) Product Portfolios and Specifications
Table 94. Hualan Bio Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 95. Hualan Bio Main Business
Table 96. Hualan Bio Latest Developments
Table 97. CBPO Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 98. CBPO Albumin (as Excipient) Product Portfolios and Specifications
Table 99. CBPO Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 100. CBPO Main Business
Table 101. CBPO Latest Developments
Table 102. Shanghai RAAS Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 103. Shanghai RAAS Albumin (as Excipient) Product Portfolios and Specifications
Table 104. Shanghai RAAS Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 105. Shanghai RAAS Main Business
Table 106. Shanghai RAAS Latest Developments
Table 107. Kedrion Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 108. Kedrion Albumin (as Excipient) Product Portfolios and Specifications
Table 109. Kedrion Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 110. Kedrion Main Business
Table 111. Kedrion Latest Developments
Table 112. LFB Group Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 113. LFB Group Albumin (as Excipient) Product Portfolios and Specifications
Table 114. LFB Group Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 115. LFB Group Main Business
Table 116. LFB Group Latest Developments
Table 117. Albumedix Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 118. Albumedix Albumin (as Excipient) Product Portfolios and Specifications
Table 119. Albumedix Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 120. Albumedix Main Business
Table 121. Albumedix Latest Developments
Table 122. Biotest Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 123. Biotest Albumin (as Excipient) Product Portfolios and Specifications
Table 124. Biotest Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 125. Biotest Main Business
Table 126. Biotest Latest Developments
Table 127. Merck Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 128. Merck Albumin (as Excipient) Product Portfolios and Specifications
Table 129. Merck Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 130. Merck Main Business
Table 131. Merck Latest Developments
Table 132. Ventria (InVitria) Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 133. Ventria (InVitria) Albumin (as Excipient) Product Portfolios and Specifications
Table 134. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 135. Ventria (InVitria) Main Business
Table 136. Ventria (InVitria) Latest Developments
Table 137. HiMedia Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 138. HiMedia Albumin (as Excipient) Product Portfolios and Specifications
Table 139. HiMedia Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 140. HiMedia Main Business
Table 141. HiMedia Latest Developments
LIST OFFIGURES
Figure 1. Picture of Albumin (as Excipient)
Figure 2. Albumin (as Excipient) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Albumin (as Excipient) Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Albumin (as Excipient) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Albumin (as Excipient) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Albumin (as Excipient) Sales Market Share by Country/Region (2024)
Figure 10. Albumin (as Excipient) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Human Serum Albumin
Figure 12. Product Picture of Recombinant Albumin
Figure 13. Global Albumin (as Excipient) Sales Market Share byType in 2025
Figure 14. Global Albumin (as Excipient) Revenue Market Share byType (2020-2025)
Figure 15. Albumin (as Excipient) Consumed in Cell Culture Media
Figure 16. Global Albumin (as Excipient) Market: Cell Culture Media (2020-2025) & (MT)
Figure 17. Albumin (as Excipient) Consumed in Medical Supplements
Figure 18. Global Albumin (as Excipient) Market: Medical Supplements (2020-2025) & (MT)
Figure 19. Albumin (as Excipient) Consumed inTherapeutics
Figure 20. Global Albumin (as Excipient) Market:Therapeutics (2020-2025) & (MT)
Figure 21. Global Albumin (as Excipient) Sale Market Share by Application (2024)
Figure 22. Global Albumin (as Excipient) Revenue Market Share by Application in 2025
Figure 23. Albumin (as Excipient) Sales by Company in 2025 (MT)
Figure 24. Global Albumin (as Excipient) Sales Market Share by Company in 2025
Figure 25. Albumin (as Excipient) Revenue by Company in 2025 ($ millions)
Figure 26. Global Albumin (as Excipient) Revenue Market Share by Company in 2025
Figure 27. Global Albumin (as Excipient) Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Albumin (as Excipient) Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Albumin (as Excipient) Sales 2020-2025 (MT)
Figure 30. Americas Albumin (as Excipient) Revenue 2020-2025 ($ millions)
Figure 31. APAC Albumin (as Excipient) Sales 2020-2025 (MT)
Figure 32. APAC Albumin (as Excipient) Revenue 2020-2025 ($ millions)
Figure 33. Europe Albumin (as Excipient) Sales 2020-2025 (MT)
Figure 34. Europe Albumin (as Excipient) Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Albumin (as Excipient) Sales 2020-2025 (MT)
Figure 36. Middle East & Africa Albumin (as Excipient) Revenue 2020-2025 ($ millions)
Figure 37. Americas Albumin (as Excipient) Sales Market Share by Country in 2025
Figure 38. Americas Albumin (as Excipient) Revenue Market Share by Country (2020-2025)
Figure 39. Americas Albumin (as Excipient) Sales Market Share byType (2020-2025)
Figure 40. Americas Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Figure 41. United States Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Albumin (as Excipient) Sales Market Share by Region in 2025
Figure 46. APAC Albumin (as Excipient) Revenue Market Share by Region (2020-2025)
Figure 47. APAC Albumin (as Excipient) Sales Market Share byType (2020-2025)
Figure 48. APAC Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Figure 49. China Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 53. India Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Albumin (as Excipient) Sales Market Share by Country in 2025
Figure 57. Europe Albumin (as Excipient) Revenue Market Share by Country (2020-2025)
Figure 58. Europe Albumin (as Excipient) Sales Market Share byType (2020-2025)
Figure 59. Europe Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Figure 60. Germany Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 61.France Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Albumin (as Excipient) Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Albumin (as Excipient) Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Figure 68. Egypt Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Albumin (as Excipient) Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Albumin (as Excipient) in 2025
Figure 74. Manufacturing Process Analysis of Albumin (as Excipient)
Figure 75. Industry Chain Structure of Albumin (as Excipient)
Figure 76. Channels of Distribution
Figure 77. Global Albumin (as Excipient) Sales MarketForecast by Region (2026-2031)
Figure 78. Global Albumin (as Excipient) Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Albumin (as Excipient) Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Albumin (as Excipient) Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Albumin (as Excipient) Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Albumin (as Excipient) Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Immune Thrombocytopenia Drugs Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
December 2025
90 pages
Global Bradycardia Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
175 pages
Global Smart Home Healthcare Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
103 pages
Global Liver Cancer Therapeutics Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
82 pages
